Physician profile
Jeffrey Gilligan
NPI 1073909024
$11,945.27
in general payments reported to CMS, 2019-2025
13 companies · $1,630 in 2025
The $1,630 reported for 2025 was more than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $3,280 · 2023: $6,400 · 2024: $636 · 2025: $1,630.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $5,846 · Food and Beverage: $2,819.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $5,845.99 |
| Food and Beverage | $2,819.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Globus Medical, INC. | $5,165.47 | 2022-2025 | Elsa, Elsa Al/Atp, Caliber, Excelsiusgps Robotic Navigation System |
| Stryker Corporation | $4,602.49 | 2022-2024 | Everest Spinal System, Spinemap, N/A |
| Si-Bone, INC. | $558.90 | 2022-2024 | |
| Depuy Synthes Sales INC. | $474.18 | 2022-2025 | Fibergraft Bg Morsels, Symphony, Expedium |
| Medtronic, INC. | $333.03 | 2022-2025 | Intellis Adaptivestim |
| Nevro Corp. | $261.41 | 2022-2024 | Senza |
| Saluda Medical Americas, INC. | $200.50 | 2025 | Evoke |
| Nuvasive, INC. | $190.15 | 2022 | |
| Dilon Technologies, INC. | $47.66 | 2025 | Hemoblast Bellows |
| Cerapedics INC. | $36.05 | 2024 | I-Factor Peptide Enhanced Bone Graft |
| Sanara Medtech INC. | $34.57 | 2024 | Celleraterx |
| Lemaitre Vascular, INC. | $20.73 | 2025 | Anastoclip Gc 8cm (Medium) |
| Orthofix Medical, INC. | $20.13 | 2023 | Spinal-Stim, Spinal-Stim |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Gilligan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.